The latest biotech news

News and Trends 16 Apr 2019

Male-Pattern Baldness Could See First New Treatment in over 10 Years

A skin cream developed by the Italian company Cassiopea has reduced male-pattern baldness for up to 12 months in a phase II trial. Androgenetic alopecia, commonly known as male-pattern baldness in men, is a very common condition where excess male hormones (androgens) in hair follicles stop hair growing on the scalp. There are only two […]

April 16, 2019 - 2 minutesmins - By Jonathan Smith

promethera liver failure stem cell therapy

News and Trends 15 Apr 2019

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as jaundice, in patients with acute liver failure, a condition with no effective treatments. A phase I/IIa trial of the therapy recruited 19 patients with chronic liver disease. Of these,12 patients had developed acute-on-chronic liver failure, a life-threatening syndrome where the […]

April 15, 2019 - 2 minutesmins - By Jonathan Smith

sophia genetics ai genomics cancer diagnostic

News and Trends 11 Apr 2019

Swiss Multi-Cancer Diagnostic Test Approved in Europe

A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors by looking at genetic variations in 42 genes. SOPHiA GENETICS works in data-driven medicine, using huge amounts of genomic data to diagnose and personalize treatments to a patient. This new technology is being adopted by […]

April 11, 2019 - 2 minutesmins - By Jonathan Smith

bubonic plague y pestis enesi pharma university of Oxford feal

News and Trends 10 Apr 2019

Needle-Free Vaccine for Bubonic Plague to be Developed in the UK

The UK biotech Enesi Pharma has joined forces with researchers from the University of Oxford to develop a vaccine for the bubonic plague that is simple to use and doesn’t require needles. Caused by the bacteria Yersinia pestis, the bubonic plague is infamous for having killed over 50 million Europeans in the Middle Ages. While […]

April 10, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Apr 2019

French First-in-Class Diabetes Drug Nails Phase III Trial

An oral first-in-class drug targeting the mitochondria, developed by the French biotech Poxel, has shown big potential for treating type 2 diabetes in a phase III trial in Japan. Poxel’s lead candidate drug imeglimin has taken a step closer to entering the huge market for diabetes type 2 treatments. In a phase III trial in […]

April 9, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 8 Apr 2019

AACR 2019: European Biotech Progresses in Fighting Cancer

The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the newest advances in cancer treatment from around the world. Sit back as we give you a quick rundown of the most interesting presentations from European organizations working to improve the treatment of cancer. Clinical trials In the conference last […]

April 8, 2019 - 4 minutesmins - By Jonathan Smith

GSK ViiV Healthcare Double HIV Treatment

News and Trends 4 Apr 2019

Update: Two-Drug HIV Treatment Effective for up to Three Years

Update (04/04/2019): ViiV Healthcare’s two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for up to three years in patients’ blood. In a clinical study, 513 HIV-infected people switched to daily pills of Juluca from their standard drug regimes, which included three or four different drugs. Juluca was effective at suppressing the virus for […]

April 4, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Lonza Chr Hansen Microbiome Manufacturing

News and Trends 3 Apr 2019

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

Lonza, a Swiss pharma supplier, and Chr. Hansen, a Danish supplier of bacterial products, are teaming up to enter the promising microbiome space. Together, the two companies will invest €90M in the creation of the first company that will offer a full supply chain to produce treatments made of live bacteria. Their 50/50 joint venture […]

April 3, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

chemical burns manchester cornea stem cells

News and Trends 3 Apr 2019

UK Scientists Activate Stem Cells to Heal Corneal Injuries

A group of researchers in the UK has developed a potential treatment for corneal injuries, such as those caused by chemical burns, by making surrounding tissue softer and letting stem cells regenerate damaged tissue. The cornea is a transparent tissue that is important for focusing light onto the retina and guarding entry into the eye. […]

April 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 2 Apr 2019

Spare Parts: Exploring the Science of Repairing the Human Body

London’s Science Gallery has gathered scientists and artists to create an exhibition that lets visitors peek at a not-so-distant future where custom implants and organ regeneration become the norm. The field of regenerative medicine has taken huge strides forward in recent years. Today, there’s talk of stem cells, smart implants, and 3D-printed organs all over […]

April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

cambridge innovation capital fund university

News and Trends 1 Apr 2019

Cambridge Fund Raises €175M to Supercharge Local Life Sciences Ecosystem

The UK venture capital fund Cambridge Innovation Capital, backed by the University of Cambridge, has raised €175M (£150M) to spend on life science and technology companies in the Cambridge area. The money will support the 25 companies in the fund’s portfolio, including the biotech Bicycle Therapeutics, whose peptide-toxin molecules are in clinical trials for the […]

April 1, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 29 Mar 2019

Liquid Biopsy for Lung Cancer Gets €46M Boost

Inivata has raised a €46M (£40M) Series B round that will further advance the commercialization of the company’s blood test for lung cancer as well as the development of new tests. Investors include Woodford patient Capital Trust, IP Group, Cambridge Innovation Capital, Johnson & Johnson Innovation and RT Ventures. Based in both the US and […]

March 29, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Male-Pattern Baldness Could See First New Treatment in over 10 Years

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

Swiss Multi-Cancer Diagnostic Test Approved in Europe

Needle-Free Vaccine for Bubonic Plague to be Developed in the UK

French First-in-Class Diabetes Drug Nails Phase III Trial

AACR 2019: European Biotech Progresses in Fighting Cancer

Update: Two-Drug HIV Treatment Effective for up to Three Years

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

UK Scientists Activate Stem Cells to Heal Corneal Injuries

Spare Parts: Exploring the Science of Repairing the Human Body

Cambridge Fund Raises €175M to Supercharge Local Life Sciences Ecosystem

Liquid Biopsy for Lung Cancer Gets €46M Boost

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!